Clinical Trial Update: Safety of Intrathecal Riluzole in Patients With Amyotrophic Lateral Sclerosis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety of intrathecal riluzole in people with amyotrophic lateral sclerosis; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Motor Neuron Disease

Drugs mentioned

• Riluzole (riluzole)

Snippet

Sponsor: Brain Trust Bio | Conditions: Amyotrophic Lateral Sclerosis, Motor Neuron Disease | Phase 1 | Status: NOT_YET_RECRUITING